| Amgen (AMGN) |
United States |
$143.760B |
15.12 |
| Bristol Myers Squibb (BMY) |
United States |
$121.252B |
7.63 |
| Gilead Sciences (GILD) |
United States |
$93.376B |
11.93 |
| Vertex Pharmaceuticals (VRTX) |
United States |
$89.750B |
26.44 |
| Regeneron Pharmaceuticals (REGN) |
United States |
$89.340B |
21.56 |
| CSL (CSLLY) |
Australia |
$78.015B |
0.00 |
| GSK (GSK) |
United Kingdom |
$74.222B |
10.07 |
| Seagen (SGEN) |
United States |
$39.820B |
0.00 |
| Moderna (MRNA) |
United States |
$39.311B |
38.11 |
| Biogen (BIIB) |
United States |
$37.221B |
15.83 |
| Argenex SE (ARGX) |
Netherlands |
$28.779B |
0.00 |
| Horizon Therapeutics Public (HZNP) |
Ireland |
$26.492B |
25.77 |
| BioNTech SE (BNTX) |
Germany |
$26.181B |
6.09 |
| Genmab (GMAB) |
Denmark |
$23.298B |
35.27 |
| Alnylam Pharmaceuticals (ALNY) |
United States |
$22.138B |
0.00 |
| Illumina (ILMN) |
United States |
$21.731B |
156.00 |
| BeiGene (BGNE) |
Cayman Islands |
$17.420B |
0.00 |
| BioMarin Pharmaceutical (BMRN) |
United States |
$16.650B |
88.48 |
| Incyte (INCY) |
United States |
$12.946B |
31.57 |
| Exact Sciences (EXAS) |
United States |
$12.325B |
0.00 |
| Legend Biotech (LEGN) |
United States |
$11.088B |
0.00 |
| Bio-Techne Corp (TECH) |
United States |
$10.771B |
38.40 |
| Sarepta Therapeutics (SRPT) |
United States |
$10.667B |
0.00 |
| Verona Pharma American Depositary Share (VRNA) |
United Kingdom |
$10.361B |
0.00 |
| Bio-Rad Laboratories (BIO.B) |
United States |
$10.324B |
28.98 |
| QIAGEN (QGEN) |
Netherlands |
$9.234B |
19.47 |
| Roivant Sciences (ROIV) |
United Kingdom |
$9.014B |
0.00 |
| Repligen (RGEN) |
United States |
$8.866B |
60.69 |
| Exelixis (EXEL) |
United States |
$6.957B |
42.84 |
| Sino Biopharmaceutical (SBMFF) |
Hong Kong, SAR China |
$6.397B |
0.00 |
| Karuna Therapeutics (KRTX) |
United States |
$6.369B |
0.00 |
| Swedish Orphan Biovitrum (BIOVF) |
Sweden |
$6.139B |
19.81 |
| Ascendis Pharma (ASND) |
Denmark |
$5.352B |
0.00 |
| Halozyme Therapeutics (HALO) |
United States |
$5.039B |
16.98 |
| Immunovant (IMVT) |
United States |
$5.017B |
0.00 |
| Intra-Cellular Therapies (ITCI) |
United States |
$4.997B |
0.00 |
| Vaxcyte (PCVX) |
United States |
$4.784B |
0.00 |
| Alkermes (ALKS) |
Ireland |
$4.665B |
233.42 |
| Apellis Pharmaceuticals (APLS) |
United States |
$4.479B |
0.00 |
| Ginkgo Bioworks Holdings (DNA) |
United States |
$3.799B |
0.00 |
| Insmed (INSM) |
United States |
$3.631B |
0.00 |
| CRISPR Therapeutics AG (CRSP) |
Switzerland |
$3.604B |
0.00 |
| MoonLake Immunotherapeutics (MLTX) |
Switzerland |
$3.559B |
0.00 |
| Amicus Therapeutics (FOLD) |
United States |
$3.491B |
0.00 |
| Guardant Health (GH) |
United States |
$3.488B |
0.00 |
| ACADIA Pharmaceuticals (ACAD) |
United States |
$3.412B |
0.00 |
| Axsome Therapeutics (AXSM) |
United States |
$3.298B |
0.00 |
| Krystal Biotech (KRYS) |
United States |
$3.247B |
0.00 |
| Blueprint Medicines (BPMC) |
United States |
$3.047B |
0.00 |
| HUTCHMED (China) (HCM) |
Hong Kong, SAR China |
$2.951B |
0.00 |
| Denali Therapeutics (DNLI) |
United States |
$2.835B |
0.00 |
| Cytokinetics (CYTK) |
United States |
$2.828B |
0.00 |
| Akero Therapeutics (AKRO) |
United States |
$2.812B |
0.00 |
| Intellia Therapeutics (NTLA) |
United States |
$2.798B |
0.00 |
| Nuvalent (NUVL) |
United States |
$2.621B |
0.00 |
| Prothena (PRTA) |
Ireland |
$2.581B |
0.00 |
| Mirati Therapeutics (MRTX) |
United States |
$2.553B |
0.00 |
| Ultragenyx Pharmaceutical (RARE) |
United States |
$2.549B |
0.00 |
| Immunocore Holdings (IMCR) |
United Kingdom |
$2.540B |
0.00 |
| Fortrea Holdings (FTRE) |
United States |
$2.539B |
0.00 |
| Zai Lab (ZLAB) |
China |
$2.403B |
0.00 |
| Certara (CERT) |
United States |
$2.323B |
38.26 |
| Galapagos (GLPG) |
Belgium |
$2.277B |
0.00 |
| Zealand Pharma (ZLDPF) |
Denmark |
$2.239B |
0.00 |
| Xenon Pharmaceuticals (XENE) |
Canada |
$2.191B |
0.00 |
| Ventyx Biosciences (VTYX) |
United States |
$2.039B |
0.00 |
| Harmony Biosciences Holdings (HRMY) |
United States |
$1.966B |
10.92 |
| Structure Therapeutics (GPCR) |
United States |
$1.929B |
0.00 |
| Beam Therapeutics (BEAM) |
United States |
$1.905B |
0.00 |
| Dynavax Technologies (DVAX) |
United States |
$1.902B |
20.51 |
| Biohaven (BHVN) |
United States |
$1.777B |
0.00 |
| Bavarian Nordic (BVNRY) |
Denmark |
$1.737B |
10.47 |
| Arcellx (ACLX) |
United States |
$1.735B |
0.00 |
| Rocket Pharmaceuticals (RCKT) |
United States |
$1.650B |
0.00 |
| Vericel (VCEL) |
United States |
$1.597B |
0.00 |
| NeoGenomics (NEO) |
United States |
$1.569B |
0.00 |
| IDEAYA Biosciences (IDYA) |
United States |
$1.553B |
0.00 |
| CureVac (CVAC) |
Germany |
$1.529B |
0.00 |
| SpringWorks Therapeutics (SWTX) |
United States |
$1.447B |
0.00 |
| Zentalis Pharmaceuticals (ZNTL) |
United States |
$1.416B |
0.00 |
| Arcus Biosciences (RCUS) |
United States |
$1.337B |
0.00 |
| AbCellera Biologics (ABCL) |
Canada |
$1.331B |
0.00 |
| Myriad Genetics (MYGN) |
United States |
$1.313B |
0.00 |
| Rhythm Pharmaceuticals (RYTM) |
United States |
$1.304B |
0.00 |
| Celldex Therapeutics (CLDX) |
United States |
$1.301B |
0.00 |
| Vir Biotechnology (VIR) |
United States |
$1.258B |
0.00 |
| Kiniksa Pharmaceuticals (KNSA) |
Bermuda |
$1.219B |
32.77 |
| Mirum Pharmaceuticals (MIRM) |
United States |
$1.210B |
0.00 |
| ANI Pharmaceuticals (ANIP) |
United States |
$1.178B |
18.85 |
| Merus (MRUS) |
Netherlands |
$1.176B |
0.00 |
| 89BIO (ETNB) |
United States |
$1.165B |
0.00 |
| Twist Bioscience (TWST) |
United States |
$1.163B |
0.00 |
| Tango Therapeutics (TNGX) |
United States |
$1.146B |
0.00 |
| Iovance Biotherapeutics (IOVA) |
United States |
$1.127B |
0.00 |
| Geron (GERN) |
United States |
$1.110B |
0.00 |
| MannKind (MNKD) |
United States |
$1.108B |
0.00 |
| Viking Therapeutics (VKTX) |
United States |
$1.107B |
0.00 |
| Morphic Holding (MORF) |
United States |
$1.098B |
0.00 |
| Apogee Therapeutics (APGE) |
United States |
$1.079B |
0.00 |
| Disc Medicine (IRON) |
United States |
$1.075B |
0.00 |
| Day One Biopharmaceuticals (DAWN) |
United States |
$1.067B |
0.00 |
| Arvinas (ARVN) |
United States |
$1.050B |
0.00 |
| Ligand Pharmaceuticals (LGND) |
United States |
$1.040B |
23.05 |
| Pliant Therapeutics (PLRX) |
United States |
$1.038B |
0.00 |
| Northwest Biotherapeutics (NWBO) |
United States |
$1.032B |
0.00 |
| Replimune (REPL) |
United States |
$1.009B |
0.00 |
| Syndax Pharmaceuticals (SNDX) |
United States |
$1.009B |
0.00 |
| Revance Therapeutics (RVNC) |
United States |
$1.009B |
0.00 |
| Deciphera Pharmaceuticals (DCPH) |
United States |
$1.003B |
0.00 |
| ACELYRIN, INC (SLRN) |
United States |
$0.989B |
0.00 |
| Protagonist Therapeutics (PTGX) |
United States |
$0.960B |
0.00 |
| Keros Therapeutics (KROS) |
United States |
$0.946B |
0.00 |
| Prime Medicine (PRME) |
United States |
$0.928B |
0.00 |
| Immatics (IMTX) |
Germany |
$0.888B |
0.00 |
| Belite Bio (BLTE) |
United States |
$0.867B |
0.00 |
| Pharming Group (PHGUF) |
Netherlands |
$0.848B |
0.00 |
| MiMedx (MDXG) |
United States |
$0.846B |
0.00 |
| Cogent Biosciences (COGT) |
United States |
$0.833B |
0.00 |
| ADMA Biologics Inc (ADMA) |
United States |
$0.805B |
0.00 |
| Inhibrx (INBX) |
United States |
$0.801B |
0.00 |
| Adaptive Biotechnologies (ADPT) |
United States |
$0.788B |
0.00 |
| Adaptimmune Therapeutics (ADAP) |
United Kingdom |
$0.775B |
0.00 |
| Intercept Pharmaceuticals (ICPT) |
United States |
$0.775B |
0.00 |
| ImmunityBio (IBRX) |
United States |
$0.771B |
0.00 |
| Kymera Therapeutics (KYMR) |
United States |
$0.770B |
0.00 |
| Sana Biotechnology (SANA) |
United States |
$0.762B |
0.00 |
| Cytek Biosciences (CTKB) |
United States |
$0.753B |
0.00 |
| Pharming Group (PHAR) |
Netherlands |
$0.748B |
0.00 |
| REGENXBIO (RGNX) |
United States |
$0.724B |
0.00 |
| POINT Biopharma Global (PNT) |
United States |
$0.705B |
7.67 |
| Novavax (NVAX) |
United States |
$0.683B |
0.00 |
| Arcturus Therapeutics Holdings (ARCT) |
United States |
$0.680B |
13.45 |
| Kura Oncology (KURA) |
United States |
$0.677B |
0.00 |
| Travere Therapeutics (TVTX) |
United States |
$0.671B |
0.00 |
| Viridian Therapeutics (VRDN) |
United States |
$0.670B |
0.00 |
| HilleVax (HLVX) |
United States |
$0.651B |
0.00 |
| Sinovac Biotech (SVA) |
China |
$0.644B |
0.00 |
| Editas Medicine (EDIT) |
United States |
$0.637B |
0.00 |
| PureTech Health (PRTC) |
United States |
$0.632B |
0.00 |
| Vera Therapeutics (VERA) |
United States |
$0.608B |
0.00 |
| Cabaletta Bio (CABA) |
United States |
$0.606B |
0.00 |
| Genelux (GNLX) |
United States |
$0.604B |
0.00 |
| Bicycle Therapeutics (BCYC) |
United Kingdom |
$0.604B |
0.00 |
| Pharma Mar (PHMMF) |
Spain |
$0.600B |
0.00 |
| Avid Bioservices (CDMO) |
United States |
$0.596B |
0.00 |
| Basilea Pharmaceutica AG (BPMUF) |
Switzerland |
$0.593B |
0.00 |
| Tyra Biosciences (TYRA) |
United States |
$0.592B |
0.00 |
| Phathom Pharmaceuticals (PHAT) |
United States |
$0.589B |
0.00 |
| Tarsus Pharmaceuticals (TARS) |
United States |
$0.580B |
0.00 |
| Rapt Therapeutics (RAPT) |
United States |
$0.571B |
0.00 |
| WAVE Life Sciences (WVE) |
Singapore |
$0.569B |
0.00 |
| Alector (ALEC) |
United States |
$0.543B |
0.00 |
| Anavex Life Sciences (AVXL) |
United States |
$0.537B |
0.00 |
| Allogene Therapeutics (ALLO) |
United States |
$0.531B |
0.00 |
| Entrada Therapeutics (TRDA) |
United States |
$0.525B |
0.00 |
| Olema Pharmaceuticals (OLMA) |
United States |
$0.511B |
0.00 |
| Repare Therapeutics (RPTX) |
Canada |
$0.509B |
0.00 |
| Biomea Fusion (BMEA) |
United States |
$0.490B |
0.00 |
| IGM Biosciences (IGMS) |
United States |
$0.487B |
0.00 |
| AnaptysBio (ANAB) |
United States |
$0.477B |
0.00 |
| Avidity Biosciences (RNA) |
United States |
$0.473B |
0.00 |
| Janux Therapeutics (JANX) |
United States |
$0.465B |
0.00 |
| 23andMe Holding (ME) |
United States |
$0.462B |
0.00 |
| Castle Biosciences (CSTL) |
United States |
$0.453B |
0.00 |
| Zymeworks (ZYME) |
United States |
$0.430B |
2.26 |
| Agenus (AGEN) |
United States |
$0.429B |
0.00 |
| Caribou Biosciences (CRBU) |
United States |
$0.422B |
0.00 |
| Liquidia Technologies (LQDA) |
United States |
$0.410B |
0.00 |
| Autolus Therapeutics (AUTL) |
United Kingdom |
$0.405B |
0.00 |
| Oculis Holding AG (OCS) |
Switzerland |
$0.400B |
0.00 |
| Scholar Rock Holding (SRRK) |
United States |
$0.399B |
0.00 |
| Nautilus Biotechnology (NAUT) |
United States |
$0.395B |
0.00 |
| ITeos Therapeutics (ITOS) |
United States |
$0.392B |
0.00 |
| Mineralys Therapeutics (MLYS) |
United States |
$0.389B |
0.00 |
| Icosavax (ICVX) |
United States |
$0.388B |
0.00 |
| Cullinan Oncology (CGEM) |
United States |
$0.387B |
0.00 |
| Nurix Therapeutics (NRIX) |
United States |
$0.379B |
0.00 |
| Aerovate Therapeutics (AVTE) |
United States |
$0.375B |
0.00 |
| Amarin (AMRN) |
Ireland |
$0.372B |
0.00 |
| Edgewise Therapeutics (EWTX) |
United States |
$0.364B |
0.00 |
| Precigen (PGEN) |
United States |
$0.363B |
0.00 |
| Coherus BioSciences (CHRS) |
United States |
$0.353B |
0.00 |
| AN2 Therapeutics (ANTX) |
United States |
$0.353B |
0.00 |
| Oxford BioMedica (OXBDF) |
United Kingdom |
$0.343B |
0.00 |
| Aura Biosciences (AURA) |
United States |
$0.343B |
0.00 |
| Voyager Therapeutics (VYGR) |
United States |
$0.340B |
3.41 |
| Arbutus Biopharma (ABUS) |
United States |
$0.340B |
0.00 |
| Oric Pharmaceuticals (ORIC) |
United States |
$0.330B |
0.00 |
| Urogen Pharma (URGN) |
United States |
$0.329B |
0.00 |
| Arcutis Biotherapeutics (ARQT) |
United States |
$0.327B |
0.00 |
| Bluebird Bio (BLUE) |
United States |
$0.325B |
0.00 |
| Apollomics (APLM) |
Taiwan |
$0.325B |
0.00 |
| MaxCyte (MXCT) |
United States |
$0.323B |
0.00 |
| UniQure (QURE) |
Netherlands |
$0.320B |
0.00 |
| Orchestra BioMed Holdings (OBIO) |
United States |
$0.312B |
0.00 |
| Terns Pharmaceuticals (TERN) |
United States |
$0.307B |
0.00 |
| Seres Therapeutics (MCRB) |
United States |
$0.305B |
0.00 |
| Humacyte (HUMA) |
United States |
$0.303B |
0.00 |
| Erasca (ERAS) |
United States |
$0.298B |
0.00 |
| Nuvation Bio (NUVB) |
United States |
$0.293B |
0.00 |
| MeiraGTx Holdings (MGTX) |
United States |
$0.292B |
0.00 |
| Zura Bio (ZURA) |
United States |
$0.284B |
0.00 |
| EYEPOINT PHARMACEUTICALS, INC (EYPT) |
United States |
$0.280B |
0.00 |
| Fulcrum Therapeutics (FULC) |
United States |
$0.274B |
0.00 |
| Anika Therapeutics (ANIK) |
United States |
$0.273B |
0.00 |
| Ovid Therapeutics (OVID) |
United States |
$0.271B |
0.00 |
| Lexicon Pharmaceuticals (LXRX) |
United States |
$0.267B |
0.00 |
| DBV Technologies S.A (DBVT) |
France |
$0.262B |
0.00 |
| Renovaro Biosciences (RENB) |
United States |
$0.261B |
0.00 |
| Inozyme Pharma (INZY) |
United States |
$0.259B |
0.00 |
| Third Harmonic Bio (THRD) |
United States |
$0.258B |
0.00 |
| ScPharmaceuticals (SCPH) |
United States |
$0.255B |
0.00 |
| Compass Therapeutics (CMPX) |
United States |
$0.251B |
0.00 |
| Atea Pharmaceuticals (AVIR) |
United States |
$0.250B |
0.00 |
| Vanda Pharmaceuticals (VNDA) |
United States |
$0.248B |
16.00 |
| Acumen Pharmaceuticals (ABOS) |
United States |
$0.240B |
0.00 |
| Kamada (KMDA) |
Israel |
$0.239B |
18.41 |
| AC Immune (ACIU) |
Switzerland |
$0.238B |
0.00 |
| Monte Rosa Therapeutics (GLUE) |
United States |
$0.238B |
0.00 |
| Y-mAbs Therapeutics (YMAB) |
United States |
$0.238B |
0.00 |
| Lifecore Biomedical (LFCR) |
United States |
$0.229B |
0.00 |
| Akoya Biosciences (AKYA) |
United States |
$0.228B |
0.00 |
| Immuneering (IMRX) |
United States |
$0.225B |
0.00 |
| Nuvectis Pharma (NVCT) |
United States |
$0.222B |
0.00 |
| Praxis Precision Medicines (PRAX) |
United States |
$0.220B |
0.00 |
| Inventiva S.A (IVA) |
France |
$0.217B |
0.00 |
| Sutro Biopharma (STRO) |
United States |
$0.210B |
0.00 |
| Gracell Biotechnologies (GRCL) |
China |
$0.209B |
0.00 |
| Astria Therapeutics (ATXS) |
United States |
$0.209B |
0.00 |
| Fate Therapeutics (FATE) |
United States |
$0.209B |
0.00 |
| Scilex Holding (SCLX) |
United States |
$0.209B |
0.00 |
| Poseida Therapeutics (PSTX) |
United States |
$0.207B |
0.00 |
| Verastem (VSTM) |
United States |
$0.205B |
0.00 |
| Innate Pharma S.A (IPHA) |
France |
$0.204B |
0.00 |
| CorMedix Inc (CRMD) |
United States |
$0.203B |
0.00 |
| Celcuity (CELC) |
United States |
$0.202B |
0.00 |
| Mesoblast (MESO) |
Australia |
$0.200B |
0.00 |
| 2seventy Bio (TSVT) |
United States |
$0.198B |
0.00 |
| ALX Oncology Holdings (ALXO) |
United States |
$0.198B |
0.00 |
| Allakos (ALLK) |
United States |
$0.197B |
0.00 |
| TELA Bio (TELA) |
United States |
$0.196B |
0.00 |
| Vigil Neuroscience (VIGL) |
United States |
$0.193B |
0.00 |
| Sagimet Biosciences (SGMT) |
United States |
$0.188B |
0.00 |
| Gossamer Bio (GOSS) |
United States |
$0.188B |
0.00 |
| Invivyd (IVVD) |
United States |
$0.187B |
0.00 |
| Ikena Oncology (IKNA) |
United States |
$0.183B |
0.00 |
| X4 Pharmaceuticals (XFOR) |
United States |
$0.179B |
0.00 |
| Merrimack Pharmaceuticals (MACK) |
United States |
$0.177B |
0.00 |
| Emergent Biosolutions (EBS) |
United States |
$0.176B |
0.00 |
| Orchard Therapeutics (ORTX) |
United Kingdom |
$0.176B |
0.00 |
| Stoke Therapeutics (STOK) |
United States |
$0.174B |
0.00 |
| Vaxxinity (VAXX) |
United States |
$0.174B |
0.00 |
| Tenaya Therapeutics (TNYA) |
United States |
$0.173B |
0.00 |
| Prima BioMed (IMMP) |
Australia |
$0.167B |
0.00 |
| GENFIT S.A (GNFT) |
France |
$0.163B |
0.00 |
| Selecta Biosciences (SELB) |
United States |
$0.163B |
0.00 |
| XOMA (XOMA) |
United States |
$0.162B |
0.00 |
| MEREO BIOPHARMA (MREO) |
United Kingdom |
$0.161B |
0.00 |
| Gritstone Bio (GRTS) |
United States |
$0.160B |
0.00 |
| LianBio (LIAN) |
United States |
$0.160B |
0.00 |
| Oncolytics Biotech (ONCY) |
Canada |
$0.158B |
0.00 |
| Applied Therapeutics (APLT) |
United States |
$0.157B |
0.00 |
| PDS Biotechnology (PDSB) |
United States |
$0.156B |
0.00 |
| Mersana Therapeutics (MRSN) |
United States |
$0.153B |
0.00 |
| Adverum Biotechnologies (ADVM) |
United States |
$0.151B |
0.00 |
| Molecular Partners AG (MOLN) |
Switzerland |
$0.150B |
0.00 |
| Atara Biotherapeutics (ATRA) |
United States |
$0.150B |
0.00 |
| Graphite Bio (GRPH) |
United States |
$0.144B |
0.00 |
| Vor Biopharma (VOR) |
|
$0.143B |
0.00 |
| Seer (SEER) |
United States |
$0.141B |
0.00 |
| Trevi Therapeutics (TRVI) |
United States |
$0.139B |
0.00 |
| Adocia (ADOCY) |
France |
$0.135B |
0.00 |
| InflaRx (IFRX) |
Germany |
$0.133B |
0.00 |
| Ocean Biomedical (OCEA) |
United States |
$0.133B |
0.00 |
| Design Therapeutics (DSGN) |
United States |
$0.132B |
0.00 |
| Codexis (CDXS) |
United States |
$0.132B |
0.00 |
| Longboard Pharmaceuticals (LBPH) |
United States |
$0.128B |
0.00 |
| Rallybio (RLYB) |
United States |
$0.127B |
0.00 |
| Annexon (ANNX) |
United States |
$0.126B |
0.00 |
| XBiotech (XBIT) |
United States |
$0.125B |
0.00 |
| Puma Biotechnology (PBYI) |
United States |
$0.125B |
0.00 |
| Mind Medicine (MindMed) (MNMD) |
United States |
$0.124B |
0.00 |
| TScan Therapeutics (TCRX) |
United States |
$0.122B |
0.00 |
| Absci (ABSI) |
United States |
$0.122B |
0.00 |
| INmune Bio (INMB) |
United States |
$0.122B |
0.00 |
| PepGen (PEPG) |
United States |
$0.121B |
0.00 |
| Aadi Bioscience (AADI) |
United States |
$0.119B |
0.00 |
| Omega Therapeutics (OMGA) |
United States |
$0.119B |
0.00 |
| Theseus Pharmaceuticals (THRX) |
United States |
$0.117B |
0.00 |
| Vaccitech (VACC) |
United Kingdom |
$0.116B |
0.00 |
| Greenwich LifeSciences (GLSI) |
United States |
$0.114B |
0.00 |
| ChromaDex (CDXC) |
United States |
$0.110B |
0.00 |
| I-Mab (IMAB) |
China |
$0.109B |
0.00 |
| Gamida Cell (GMDA) |
United States |
$0.109B |
0.00 |
| Rani Therapeutics Holdings (RANI) |
United States |
$0.108B |
0.00 |
| Bionano Genomics (BNGO) |
United States |
$0.107B |
0.00 |
| Eton Pharmaceuticals (ETON) |
United States |
$0.107B |
0.00 |
| Sangamo Therapeutics (SGMO) |
United States |
$0.106B |
0.00 |
| ProQR Therapeutics (PRQR) |
Netherlands |
$0.105B |
0.00 |
| Inovio Pharmaceuticals (INO) |
United States |
$0.104B |
0.00 |
| Abeona Therapeutics (ABEO) |
United States |
$0.104B |
0.00 |
| Milestone Pharmaceuticals (MIST) |
Canada |
$0.103B |
0.00 |
| Cue Biopharma (CUE) |
United States |
$0.103B |
0.00 |
| Ocugen (OCGN) |
United States |
$0.103B |
0.00 |
| MediciNova (MNOV) |
United States |
$0.103B |
0.00 |
| Immunome (IMNM) |
United States |
$0.102B |
0.00 |
| Opthea (OPT) |
Australia |
$0.102B |
0.00 |
| ANIXA BIOSCIENCES INC (ANIX) |
United States |
$0.102B |
0.00 |
| BRIACELL THERAP (BCTX) |
Canada |
$0.100B |
0.00 |
| PhenomeX (CELL) |
United States |
$0.099B |
0.00 |
| DiaMedica Therapeutics (DMAC) |
United States |
$0.098B |
0.00 |
| Kodiak Sciences (KOD) |
United States |
$0.094B |
0.00 |
| Genenta Science S.p.A (GNTA) |
Italy |
$0.094B |
0.00 |
| IO Biotech (IOBT) |
Denmark |
$0.093B |
0.00 |
| Spruce Biosciences (SPRB) |
United States |
$0.092B |
0.00 |
| C4 Therapeutics (CCCC) |
United States |
$0.092B |
0.00 |
| Cara Therapeutics (CARA) |
United States |
$0.091B |
0.00 |
| ATyr Pharma (LIFE) |
United States |
$0.090B |
0.00 |
| Turnstone Biologics (TSBX) |
United States |
$0.090B |
0.00 |
| NGM Biopharmaceuticals (NGM) |
United States |
$0.089B |
0.00 |
| Cellectis S.A (CLLS) |
France |
$0.088B |
0.00 |
| Kezar Life Sciences (KZR) |
United States |
$0.087B |
0.00 |
| CytomX Therapeutics (CTMX) |
United States |
$0.086B |
0.00 |
| Graf Acquisition IV (GFOR) |
United States |
$0.086B |
0.00 |
| Annovis Bio (ANVS) |
United States |
$0.086B |
0.00 |
| Data Knights Acquisition (DKDCA) |
United Kingdom |
$0.085B |
0.00 |
| Cidara Therapeutics (CDTX) |
United States |
$0.085B |
0.00 |
| Syros Pharmaceuticals (SYRS) |
United States |
$0.082B |
0.00 |
| BioAtla (BCAB) |
United States |
$0.081B |
0.00 |
| Compugen (CGEN) |
Israel |
$0.081B |
0.00 |
| Alpha Teknova (TKNO) |
United States |
$0.079B |
0.00 |
| Anebulo Pharmaceuticals (ANEB) |
United States |
$0.078B |
0.00 |
| Jasper Therapeutics (JSPR) |
United States |
$0.078B |
0.00 |
| Athira Pharma (ATHA) |
United States |
$0.077B |
0.00 |
| Werewolf Therapeutics (HOWL) |
United States |
$0.076B |
0.00 |
| Kronos Bio (KRON) |
United States |
$0.076B |
0.00 |
| G1 Therapeutics (GTHX) |
United States |
$0.075B |
0.00 |
| Genetron Holdings (GTH) |
China |
$0.074B |
0.00 |
| BioXcel Therapeutics (BTAI) |
United States |
$0.074B |
0.00 |
| Evelo Biosciences (EVLO) |
United States |
$0.074B |
0.00 |
| Beyond Air (XAIR) |
United States |
$0.073B |
0.00 |
| Corvus Pharmaceuticals (CRVS) |
United States |
$0.071B |
0.00 |
| Affimed (AFMD) |
Germany |
$0.071B |
0.00 |
| Elicio Therapeutics (ELTX) |
United States |
$0.071B |
0.00 |
| Ocuphire Pharma (OCUP) |
United States |
$0.070B |
3.99 |
| Enzo Biochem (ENZ) |
United States |
$0.070B |
0.00 |
| ADC Therapeutics SA (ADCT) |
Switzerland |
$0.069B |
0.00 |
| AVROBIO (AVRO) |
United States |
$0.069B |
0.00 |
| HCW Biologics (HCWB) |
United States |
$0.068B |
0.00 |
| Nkarta (NKTX) |
United States |
$0.068B |
0.00 |
| Tiziana Life Sciences (TLSA) |
United Kingdom |
$0.067B |
0.00 |
| Immix Biopharma (IMMX) |
United States |
$0.067B |
0.00 |
| Adagene (ADAG) |
China |
$0.067B |
0.00 |
| Prenetics Global (PRE) |
Cayman Islands |
$0.066B |
1.56 |
| Kinnate Biopharma (KNTE) |
United States |
$0.066B |
0.00 |
| Immunic (IMUX) |
United States |
$0.066B |
0.00 |
| Shattuck Labs (STTK) |
United States |
$0.065B |
0.00 |
| Spero Therapeutics (SPRO) |
United States |
$0.064B |
0.00 |
| Clene (CLNN) |
United States |
$0.064B |
0.00 |
| Eyenovia (EYEN) |
United States |
$0.063B |
0.00 |
| Cardiff Oncology (CRDF) |
United States |
$0.062B |
0.00 |
| Adicet Bio (ACET) |
United States |
$0.059B |
0.00 |
| Xilio Therapeutics (XLO) |
United States |
$0.058B |
0.00 |
| Oncobiologics (OTLK) |
United States |
$0.058B |
0.00 |
| Instil Bio (TIL) |
United States |
$0.056B |
0.00 |
| Dyadic (DYAI) |
United States |
$0.055B |
0.00 |
| Intensity Therapeutics (INTS) |
United States |
$0.054B |
0.00 |
| Clearside Biomedical (CLSD) |
United States |
$0.054B |
0.00 |
| Theratechnologies (THTX) |
Canada |
$0.052B |
0.00 |
| Dianthus Therapeutics (DNTH) |
United States |
$0.052B |
0.00 |
| Sorrento Therapeutics (SRNEQ) |
United States |
$0.052B |
0.00 |
| HOOKIPA Pharma (HOOK) |
United States |
$0.052B |
0.00 |
| Solid Biosciences (SLDB) |
United States |
$0.051B |
0.00 |
| VTv Therapeutics (VTVT) |
United States |
$0.050B |
0.00 |
| Aeglea BioTherapeutics (AGLE) |
United States |
$0.050B |
0.00 |
| Longeveron (LGVN) |
United States |
$0.050B |
0.00 |
| VistaGen Therapeutics (VTGN) |
United States |
$0.049B |
0.00 |
| Rezolute (RZLT) |
United States |
$0.049B |
0.00 |
| OKYO Pharma (OKYO) |
|
$0.047B |
0.00 |
| Science 37 Holdings (SNCE) |
United States |
$0.047B |
0.00 |
| Galena Biopharma (SLS) |
United States |
$0.046B |
0.00 |
| Connect Biopharma Holdings (CNTB) |
United States |
$0.045B |
0.00 |
| Femasys (FEMY) |
United States |
$0.045B |
0.00 |
| Cognition Therapeutics (CGTX) |
United States |
$0.044B |
0.00 |
| Celularity (CELU) |
United States |
$0.042B |
0.00 |
| Quince Therapeutics (QNCX) |
United States |
$0.041B |
0.00 |
| Dare Bioscience (DARE) |
United States |
$0.041B |
0.00 |
| Bolt Biotherapeutics (BOLT) |
United States |
$0.039B |
0.00 |
| Precision BioSciences (DTIL) |
United States |
$0.039B |
0.00 |
| Curis (CRIS) |
United States |
$0.039B |
0.00 |
| Fortress Biotech (FBIO) |
United States |
$0.039B |
0.00 |
| CytoMed Therapeutics (GDTC) |
Singapore |
$0.038B |
0.00 |
| Coya Therapeutics (COYA) |
United States |
$0.038B |
0.00 |
| MiNK Therapeutics (INKT) |
United States |
$0.038B |
0.00 |
| Achilles Therapeutics (ACHL) |
United Kingdom |
$0.037B |
0.00 |
| Portage Biotech (PRTG) |
|
$0.037B |
0.00 |
| Lantern Pharma (LTRN) |
United States |
$0.037B |
0.00 |
| Checkpoint Therapeutics (CKPT) |
United States |
$0.037B |
0.00 |
| Passage Bio (PASG) |
United States |
$0.036B |
0.00 |
| NextCure (NXTC) |
United States |
$0.036B |
0.00 |
| Miromatrix Medical (MIRO) |
United States |
$0.036B |
0.00 |
| Leap Therapeutics (LPTX) |
United States |
$0.035B |
0.00 |
| Mainz Biomed (MYNZ) |
Germany |
$0.035B |
0.00 |
| UNITY Biotechnology (UBX) |
United States |
$0.035B |
0.00 |
| Neoleukin Therapeutics (NLTX) |
United States |
$0.035B |
0.00 |
| Kineta (KA) |
United States |
$0.033B |
0.00 |
| SAB Biotherapeutics (SABS) |
United States |
$0.033B |
0.00 |
| IN8bio (INAB) |
United States |
$0.033B |
0.00 |
| Aligos Therapeutics (ALGS) |
United States |
$0.033B |
0.00 |
| Eledon Pharmaceuticals (ELDN) |
United States |
$0.032B |
0.00 |
| NuCana (NCNA) |
United Kingdom |
$0.032B |
0.00 |
| Rain Oncology (RAIN) |
United States |
$0.031B |
0.00 |
| Telesis Bio (TBIO) |
United States |
$0.031B |
0.00 |
| BeyondSpring (BYSI) |
United States |
$0.031B |
0.00 |
| Axcella Health (AXLA) |
United States |
$0.031B |
0.00 |
| ASLAN Pharmaceuticals (ASLN) |
Singapore |
$0.031B |
0.00 |
| Biora Therapeutics (BIOR) |
United States |
$0.030B |
0.00 |
| Pieris Pharmaceuticals (PIRS) |
United States |
$0.029B |
0.00 |
| Coeptis Therapeutics Holdings (COEP) |
United States |
$0.029B |
0.00 |
| Elevation Oncology (ELEV) |
United States |
$0.028B |
0.00 |
| Cyclo Therapeutics (CYTH) |
United States |
$0.027B |
0.00 |
| Alimera Sciences (ALIM) |
United States |
$0.027B |
0.00 |
| Candel Therapeutics (CADL) |
United States |
$0.027B |
0.00 |
| Lumos Pharma (LUMO) |
United States |
$0.026B |
0.00 |
| Equillium (EQ) |
United States |
$0.026B |
0.00 |
| EFFECTOR Therapeutics (EFTR) |
United States |
$0.025B |
0.00 |
| Pluri (PLUR) |
Israel |
$0.025B |
0.00 |
| Evogene (EVGN) |
Israel |
$0.024B |
0.00 |
| Forte Biosciences (FBRX) |
United States |
$0.024B |
0.00 |
| Seelos Therapeutics (SEEL) |
United States |
$0.024B |
0.00 |
| GENPREX (GNPX) |
United States |
$0.023B |
0.00 |
| Elutia (ELUT) |
United States |
$0.023B |
0.00 |
| Evaxion Biotech (EVAX) |
Denmark |
$0.023B |
0.00 |
| Alzamend Neuro (ALZN) |
United States |
$0.023B |
0.00 |
| KALA BIO (KALA) |
United States |
$0.023B |
0.00 |
| Bionomics (BNOX) |
Australia |
$0.022B |
0.00 |
| Purple Biotech (PPBT) |
Israel |
$0.022B |
0.00 |
| Vincerx Pharma (VINC) |
United States |
$0.022B |
0.00 |
| Sensei Biotherapeutics (SNSE) |
United States |
$0.021B |
0.00 |
| Entera Bio (ENTX) |
Israel |
$0.021B |
0.00 |
| YS Biopharma (YS) |
China |
$0.021B |
1.00 |
| Medicenna Therapeutics (MDNA) |
Canada |
$0.021B |
0.00 |
| Aptose Biosciences (APTO) |
Canada |
$0.020B |
0.00 |
| TradeUP Acquisition (UPTD) |
United States |
$0.020B |
0.00 |
| Acurx Pharmaceuticals (ACXP) |
United States |
$0.020B |
0.00 |
| Galecto (GLTO) |
Denmark |
$0.020B |
0.00 |
| Hepion Pharmaceuticals (HEPA) |
United States |
$0.019B |
0.00 |
| Cocrystal Pharma (COCP) |
United States |
$0.019B |
0.00 |
| Vascular Biogenics (VBLT) |
Israel |
$0.019B |
0.00 |
| Freeline Therapeutics Holdings (FRLN) |
United Kingdom |
$0.019B |
0.00 |
| Acorda Therapeutics (ACOR) |
United States |
$0.019B |
0.00 |
| Senti Biosciences (SNTI) |
United States |
$0.018B |
0.00 |
| Catalyst Biosciences (CBIO) |
United States |
$0.018B |
0.00 |
| Virios Therapeutics (VIRI) |
United States |
$0.018B |
0.00 |
| PHAXIAM Therapeutics S.A (PHXM) |
France |
$0.018B |
0.00 |
| Orgenesis (ORGS) |
United States |
$0.018B |
0.00 |
| Lisata Therapeutics (LSTA) |
United States |
$0.017B |
0.00 |
| AquaBounty Technologies (AQB) |
United States |
$0.017B |
0.00 |
| Promis Neurosciences (PMN) |
Canada |
$0.017B |
0.00 |
| Mustang Bio (MBIO) |
United States |
$0.017B |
0.00 |
| Novogen (KZIA) |
Australia |
$0.016B |
0.00 |
| Aprea Therapeutics (APRE) |
United States |
$0.016B |
0.00 |
| VBI Vaccines (VBIV) |
United States |
$0.015B |
0.00 |
| CalciMedica (CALC) |
United States |
$0.015B |
0.00 |
| Akari Therapeutics (AKTX) |
United Kingdom |
$0.015B |
0.00 |
| Genetic Technologies (GENE) |
Australia |
$0.015B |
0.00 |
| RenovoRx (RNXT) |
United States |
$0.014B |
0.00 |
| GeoVax Labs (GOVX) |
United States |
$0.014B |
0.00 |
| ZIVO Bioscience (ZIVO) |
United States |
$0.014B |
0.00 |
| Eiger BioPharmaceuticals (EIGR) |
United States |
$0.014B |
0.00 |
| Frequency Therapeutics (FREQ) |
United States |
$0.014B |
0.00 |
| Edesa Biotech (EDSA) |
Canada |
$0.013B |
0.00 |
| Senesco Technologies (ELOX) |
United States |
$0.013B |
0.00 |
| NeuroBo Pharmaceuticals (NRBO) |
United States |
$0.013B |
0.00 |
| Synlogic (SYBX) |
United States |
$0.013B |
0.00 |
| Moleculin Biotech (MBRX) |
United States |
$0.013B |
0.00 |
| TFF Pharmaceuticals (TFFP) |
United States |
$0.013B |
0.00 |
| Pasithea Therapeutics (KTTA) |
United States |
$0.013B |
0.00 |
| AEterna Zentaris (AEZS) |
Canada |
$0.012B |
0.00 |
| Landos Biopharma (LABP) |
United States |
$0.012B |
0.00 |
| Biofrontera (BFRI) |
United States |
$0.012B |
0.00 |
| Eterna Therapeutics (ERNA) |
United States |
$0.012B |
0.00 |
| IMMURON (IMRN) |
Australia |
$0.011B |
0.00 |
| Cingulate (CING) |
United States |
$0.011B |
0.00 |
| Organovo Holdings (ONVO) |
United States |
$0.011B |
0.00 |
| BioAffinity Technologies (BIAF) |
United States |
$0.011B |
0.00 |
| Talis Biomedical (TLIS) |
United States |
$0.011B |
0.00 |
| Atreca (BCEL) |
United States |
$0.010B |
0.00 |
| Aytu BioPharma (AYTU) |
United States |
$0.010B |
0.00 |
| Prana Biotechnology (ATHE) |
Australia |
$0.010B |
0.00 |
| Chemomab Therapeutics (CMMB) |
Israel |
$0.010B |
0.00 |
| GT Biopharma (GTBP) |
United States |
$0.010B |
0.00 |
| Athersys (ATHX) |
United States |
$0.010B |
0.00 |
| ARAVIVE, INC (ARAV) |
United States |
$0.010B |
0.00 |
| Virpax Pharmaceuticals (VRPX) |
United States |
$0.009B |
0.00 |
| BioCardia (BCDA) |
United States |
$0.009B |
0.00 |
| Imunon (IMNN) |
United States |
$0.009B |
0.00 |
| Brainstorm Cell Therapeutics (BCLI) |
United States |
$0.009B |
0.00 |
| Cohbar (CWBR) |
United States |
$0.009B |
0.00 |
| Cadrenal Therapeutics (CVKD) |
United States |
$0.009B |
0.00 |
| Monopar Therapeutics (MNPR) |
United States |
$0.009B |
0.00 |
| Avalon GloboCare (ALBT) |
United States |
$0.009B |
0.00 |
| Lipella Pharmaceuticals (LIPO) |
United States |
$0.009B |
0.00 |
| Biorestorative Therapies (BRTX) |
United States |
$0.008B |
0.00 |
| Trevena (TRVN) |
United States |
$0.008B |
0.00 |
| Cyclerion Therapeutics (CYCN) |
United States |
$0.008B |
0.00 |
| Sunshine Biopharma (SBFM) |
Canada |
$0.008B |
0.00 |
| Blue Water Biotech (BWV) |
United States |
$0.008B |
0.00 |
| Lexaria Bioscience (LEXX) |
Canada |
$0.008B |
0.00 |
| Atrinsic (PTIX) |
United States |
$0.008B |
0.00 |
| Comera Life Sciences Holdings (CMRA) |
United States |
$0.008B |
0.00 |
| NeuroSense Therapeutics (NRSN) |
Israel |
$0.008B |
0.00 |
| Benitec Biopharma (BNTC) |
United States |
$0.008B |
0.00 |
| Galera Therapeutics (GRTX) |
United States |
$0.008B |
0.00 |
| Pulmatrix (PULM) |
United States |
$0.007B |
0.00 |
| Tenax Therapeutics (TENX) |
United States |
$0.007B |
0.00 |
| Titan Pharmaceuticals (TTNP) |
United States |
$0.007B |
0.00 |
| Kintara Therapeutics (KTRA) |
United States |
$0.007B |
0.00 |
| Creative Medical Technology Holdings (CELZ) |
United States |
$0.007B |
0.00 |
| Aileron Therapeutics (ALRN) |
United States |
$0.007B |
0.00 |
| Biodexa Pharmaceuticals (BDRX) |
United Kingdom |
$0.006B |
0.00 |
| Biophytis SA (BPTS) |
France |
$0.006B |
0.00 |
| CervoMed (CRVO) |
United States |
$0.006B |
0.00 |
| Exicure (XCUR) |
United States |
$0.006B |
0.43 |
| Applied Molecular Transport (AMTI) |
United States |
$0.006B |
0.00 |
| Bright Minds Biosciences (DRUG) |
United States |
$0.006B |
0.00 |
| Lixte Biotechnology Holdings (LIXT) |
United States |
$0.006B |
0.00 |
| NexImmune (NEXI) |
United States |
$0.005B |
0.00 |
| TRACON Pharmaceuticals (TCON) |
United States |
$0.005B |
0.00 |
| Enveric Biosciences (ENVB) |
United States |
$0.005B |
0.00 |
| Silo Pharma (SILO) |
United States |
$0.005B |
0.00 |
| Virax Biolabs Group (VRAX) |
United Kingdom |
$0.005B |
0.00 |
| Hoth Therapeutics (HOTH) |
United States |
$0.005B |
0.00 |
| Sonnet BioTherapeutics Holdings (SONN) |
United States |
$0.005B |
0.00 |
| Vaccinex (VCNX) |
United States |
$0.005B |
0.00 |
| Windtree Therapeutics (WINT) |
United States |
$0.005B |
0.00 |
| Bellerophon Therapeutics (BLPH) |
United States |
$0.005B |
0.00 |
| CNS Pharmaceuticals (CNSP) |
United States |
$0.005B |
0.00 |
| PaxMedica (PXMD) |
United States |
$0.005B |
0.00 |
| GRI Bio (GRI) |
United States |
$0.005B |
0.00 |
| Soligenix (SNGX) |
United States |
$0.005B |
0.00 |
| Cyclacel Pharmaceuticals (CYCC) |
United States |
$0.004B |
0.00 |
| Synaptogenix (SNPX) |
United States |
$0.004B |
0.00 |
| Revelation Biosciences (REVB) |
United States |
$0.004B |
0.00 |
| Artelo Biosciences (ARTL) |
United States |
$0.004B |
0.00 |
| ABVC BioPharma (ABVC) |
United States |
$0.004B |
0.00 |
| Cardio Diagnostics Holdings (CDIO) |
United States |
$0.004B |
0.00 |
| ZyVersa Therapeutics (ZVSA) |
United States |
$0.004B |
0.00 |
| Palisade Bio (PALI) |
United States |
$0.004B |
0.04 |
| Ensysce Biosciences (ENSC) |
United States |
$0.004B |
0.00 |
| Panbela Therapeutics (PBLA) |
United States |
$0.004B |
0.00 |
| Aptevo Therapeutics (APVO) |
United States |
$0.004B |
0.00 |
| ThermoGenesis Holdings (THMO) |
United States |
$0.003B |
0.00 |
| Adial Pharmaceuticals (ADIL) |
United States |
$0.003B |
0.00 |
| Dermata Therapeutics (DRMA) |
United States |
$0.003B |
0.00 |
| 180 Life Sciences (ATNF) |
United States |
$0.003B |
0.26 |
| Aceragen (ACGN) |
United States |
$0.003B |
0.00 |
| Bone Biologics (BBLG) |
United States |
$0.002B |
0.00 |
| First Wave BioPharma (FWBI) |
United States |
$0.002B |
0.06 |
| NeuBase Therapeutics (NBSE) |
United States |
$0.002B |
0.00 |
| Allarity Therapeutics (ALLR) |
United States |
$0.002B |
0.00 |
| Invo BioScience (INVO) |
United States |
$0.002B |
0.00 |
| Scinai Immunotherapeutics (SCNI) |
Israel |
$0.002B |
0.00 |
| TC BioPharm (Holdings) (TCBP) |
United Kingdom |
$0.000B |
0.00 |
| MorphoSys AG (MOR) |
Germany |
$0.000B |
15.63 |
| Regencell Bioscience Holdings (RGC) |
Hong Kong, SAR China |
$0.000B |
0.00 |
| ARCA Biopharma (ABIO) |
United States |
$0.000B |
0.00 |
| Alvotech (ALVO) |
|
$0.000B |
0.00 |
| CollPlant Biotechnologies (CLGN) |
Israel |
$0.000B |
0.00 |
| Celyad SA (CYAD) |
Belgium |
$0.000B |
0.00 |
| GH Research (GHRS) |
Ireland |
$0.000B |
0.00 |
| LAVA Therapeutics (LVTX) |
Netherlands |
$0.000B |
0.00 |
| Motif Bio Plc (MTFB) |
United Kingdom |
$0.000B |
0.00 |
| PDL BioPharma (PDLI) |
United States |
$0.000B |
0.00 |
| Pharvaris (PHVS) |
Netherlands |
$0.000B |
0.00 |
| VectivBio Holding AG (VECT) |
Switzerland |
$0.000B |
0.00 |
